Skip to main content
Erschienen in: Reactions Weekly 1/2021

01.01.2021 | Case report

Antineoplastics

Various toxicities: 8 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Gabeeva NG, et al. Chemotherapy according to the R-mNHL-BFM-90 Protocol in combination with lenalidomide as the first line therapy in patients with mum1-positive diffusive large b-cell , lymphoma and follicular lymphoma grade 3B. [Russian]. Gematologiia i Transfuziologiia 64: 150-164, No. 2, Jan 2019. Available from: URL: http://doi.org/10.35754/0234-5730-2019-64-2-150-164 [Russian; Summarised from a translation]CrossRef Gabeeva NG, et al. Chemotherapy according to the R-mNHL-BFM-90 Protocol in combination with lenalidomide as the first line therapy in patients with mum1-positive diffusive large b-cell , lymphoma and follicular lymphoma grade 3B. [Russian]. Gematologiia i Transfuziologiia 64: 150-164, No. 2, Jan 2019. Available from: URL: http://​doi.​org/​10.​35754/​0234-5730-2019-64-2-150-164 [Russian; Summarised from a translation]CrossRef
Metadaten
Titel
Antineoplastics
Various toxicities: 8 case reports
Publikationsdatum
01.01.2021
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2021
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-87916-2

Weitere Artikel der Ausgabe 1/2021

Reactions Weekly 1/2021 Zur Ausgabe

Case report

Benzylpenicillin

Case report

Methotrexate

Case report

Antineoplastics

Case report

Pembrolizumab